This text is a result of machine translation.
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
The main force continued to increase its position in lithium battery stocks in the late trading, and sold off banks and pharmaceutical stocks
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
How Can Solar Companies Seize Opportunities in the Post-Subsidy Era?
Yesterday 05:23 PM
Mexicans Who Can’t Afford Tacos Flock to Chinese Restaurants
Oct 08, 2024 11:11 AM